ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,792, issued on April 14, was assigned to ELANCO TIERGESUNDHEIT AG (Basel, Switzerland).
"Monoclonal antibodies and methods of use" was invented by Sarah Rue (San Diego), Brendan Eckelman (San Diego), Quinn L. Deveraux (San Diego) and Marc Nasoff (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs."
The patent was filed on March 24, 2022, under Application ...